Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
Antti Hurme, Pinja Jalkanen, Jemna Heroum, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy
Paolo Cortese, Felice Amato, Antonio D’Avino, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1447-1447
Open Access | Times Cited: 6
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up
Antti Hurme, Pinja Jalkanen, Minna Marttila-Vaara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice
Raj S. Patel, Babita Agrawal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients
Yvette den Hartog, S. Reshwan K. Malahe, Wim J. R. Rietdijk, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
Arianna Gatti, Gaetano Zizzo, Massimo De Paschale, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285728-e0285728
Open Access | Times Cited: 4
Specific immune responses after BNT162b2 mRNA vaccination and COVID-19 infection
Simona Arientová, Kateřina Matúšková, Oldřich Bartoš, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Carbohydrates Metabolic Signatures in Immune Cells: Response to Infection
Kareem Awad, Amany Sayed Maghraby, Dina Nadeem Abd‐Elshafy, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
Jie Bai, Asako Chiba, Goh Murayama, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
COVID-19 vaccination: Effects of immunodominant peptides of SARS-CoV-2
Arthur Gomes de Andrade, Fernando Cézar Comberlang, Luiz Henrique Agra Cavalcante‐Silva, et al.
Cytokine (2023) Vol. 170, pp. 156339-156339
Closed Access | Times Cited: 3
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
Daniela Dalla Gasperina, Giovanni Veronesi, Carlo Maria Castelletti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13728-13728
Open Access | Times Cited: 3
Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1873-1881
Closed Access | Times Cited: 5
Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination
Wan‐Ting Huang, Shao‐Wen Weng, Hong‐Tai Tzeng, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1550-1550
Open Access | Times Cited: 5
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia
M Gambacorti Passerini, Tamar Ratishvili, Jonathon M. Monroe, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 4, pp. 874-883
Closed Access | Times Cited: 2
SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
Su-Jin Choi, Sang-Hoon Kim, Mi Seon Han, et al.
Immune Network (2023) Vol. 23, Iss. 4
Open Access | Times Cited: 2
Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections
Sun‐Woo Yoon, Kristin Widyasari, Jieun Jang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Felipe Melo-González, Constanza Méndez, Hernán F. Peñaloza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Studying the correlation of inflammatory cytokines to COVID-19 disease
Nuha A. Alkhattabi, H. Alharbi, Mohammad Basabrain, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155215-155215
Open Access
mRNA Vaccine-Induced SARS-CoV-2 Spike-Specific IFN-γ and IL-2 T-cell Responses are Predictive of Serological Neutralization and are Transiently Enhanced by Pre-Existing Cross-Reactive Immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents
Laís Albuquerque de Oliveira, Isa Rita Brito de Morais, Silvana Beutinger Marchioro, et al.
Vaccine (2024) Vol. 43, pp. 126494-126494
Closed Access
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity
Milja Belik, Arttu Reinholm, Pekka Kolehmainen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study
S Mestiri, Maysaloun Merhi, Varghese Inchakalody, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs
Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, et al.
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 84-98
Open Access | Times Cited: 1
Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence
David J. Bean, Janet Monroe, Yan Liang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
COVID-19 vaccination: A twisted web of crime
Muhammed Jasim A Jalal, R B
MGM Journal of Medical Sciences (2023) Vol. 10, Iss. 1, pp. 168-169
Open Access
Methodical and Immunological Insights of Prime COVID-19 Vaccines
Wilson Pearl Evangeline, Sakthivelnathan Divyasri, C.V. Akshaya, et al.
Coronaviruses (2023) Vol. 5, Iss. 3
Closed Access

Scroll to top